Post by Lighthouse Lab Services

The biggest reimbursement mistake many laboratories make happens long before they submit their first claim. The decisions made during test development, from validation strategy to regulatory planning, can influence payer coverage, medical-necessity reviews, and ultimately whether innovative testing achieves commercial success. During a recent webinar, we welcomed regulatory attorney Christine Bump for an in-depth discussion with Lighthouse's Ann Lambrix on the growing connection between FDA oversight and laboratory reimbursement. Whether you're developing new diagnostic testing, expanding molecular capabilities, or navigating today's increasingly complex payer environment, this discussion offers valuable insights to help your laboratory prepare for what's ahead. 🎥 Watch the recording here: https://lnkd.in/gJ2p5HEJ